ConductScience.org, home

Paper36768202

Characterization of IGF2R Molecular Expression in Canine Osteosarcoma as Part of a Novel Comparative Oncology Approach.

Boisclair C and 4 others. Int J Mol Sci, 2023. Cited by 7 papers, by iCite.

Cite this record

ConductScience Library. Characterization of IGF2R Molecular Expression in Canine Osteosarcoma as Part of a Novel Comparative Oncology Approach. Papers, record 36768202. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36768202

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Characterization of IGF2R Molecular Expression in Canine Osteosarcoma as Part of a Novel Comparative Oncology Approach.
PubMed
Journal
Int J Mol Sci
PubMed
Year
2023
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
1.14
iCite
Revised in PubMed
2023-02-16
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Boisclair CCharles
2Dickinson RRyan
3Giri SSabeena
4Dadachova EEkaterina
5MacDonald-Dickinson VValerie

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Bone NeoplasmsMajor topic
OsteosarcomaMajor topic
Animals
Dogs
Humans
Protein Binding
Receptor, IGF Type 2

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
WCVM425613Western College of Veterinary Medicine Companion Animal Health FundPubMed

Source PubMed

Download CSV of grants

References43

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125998714Radioimmunotherapy of human tumours.Nat Rev Cancer2015https://conductscience.org/library/papers/25998714PubMed
231546999Radioimmunotherapy in Non-Hodgkin's Lymphoma: Retrospective Adverse Event Profiling of Zevalin and Bexxar.Pharmaceuticals (Basel)2019https://conductscience.org/library/papers/31546999PubMed
331442327Re-treatment with radium-223: 2-year follow-up from an international, open-label, phase 1/2 study in patients with castration-resistant prostate cancer and bone metastases.Prostate2019https://conductscience.org/library/papers/31442327PubMed
419122062Use of single-agent carboplatin as adjuvant or neoadjuvant therapy in conjunction with amputation for appendicular osteosarcoma in dogs.J Am Anim Hosp Assoc2009https://conductscience.org/library/papers/19122062PubMed
527744117Targeted therapy of osteosarcoma with radiolabeled monoclonal antibody to an insulin-like growth factor-2 receptor (IGF2R).Nucl Med Biol2016https://conductscience.org/library/papers/27744117PubMed
68691094Involvement of IGF-II in human cancer.J Endocrinol1996https://conductscience.org/library/papers/8691094PubMed
728966355Retrospective evaluation of toceranib (Palladia) treatment for canine metastatic appendicular osteosarcoma.Can Vet J2017https://conductscience.org/library/papers/28966355PubMed
818046459Structure and functional analysis of the IGF-II/IGF2R interaction.EMBO J2008https://conductscience.org/library/papers/18046459PubMed
928477425Outcome and complications in dogs with appendicular primary bone tumors treated with stereotactic radiotherapy and concurrent surgical stabilization.Vet Surg2017https://conductscience.org/library/papers/28477425PubMed
1022587466Prognostic factors in canine appendicular osteosarcoma - a meta-analysis.BMC Vet Res2012https://conductscience.org/library/papers/22587466PubMed
1129284372Histologic Grade Does Not Predict Outcome in Dogs with Appendicular Osteosarcoma Receiving the Standard of Care.Vet Pathol2018https://conductscience.org/library/papers/29284372PubMed
1230768736Prognostic value of fluorine18 flourodeoxyglucose positron emission tomography/computed tomography in dogs with appendicular osteosarcoma.J Vet Intern Med2019https://conductscience.org/library/papers/30768736PubMed
1329065898Comparative review of human and canine osteosarcoma: morphology, epidemiology, prognosis, treatment and genetics.Acta Vet Scand2017https://conductscience.org/library/papers/29065898PubMed
1427776176Evaluation of CD146 as Target for Radioimmunotherapy against Osteosarcoma.PLoS One2016https://conductscience.org/library/papers/27776176PubMed
158679270Targeted radiotherapy of osteosarcoma using 153 Sm-EDTMP. A new promising approach.Acta Oncol1996https://conductscience.org/library/papers/8679270PubMed
161577656Prognosis for dogs with appendicular osteosarcoma treated by amputation alone: 162 cases (1978-1988).J Am Vet Med Assoc1992https://conductscience.org/library/papers/1577656PubMed
1730409432Targeted cancer cell ablation in mice by an α-particle-emitting astatine-211-labeled antibody against major histocompatibility complex class I chain-related protein A and B.Biochem Biophys Res Commun2018https://conductscience.org/library/papers/30409432PubMed
1821751203Cell surface receptor expression patterns in osteosarcoma.Cancer2012https://conductscience.org/library/papers/21751203PubMed
199825475Distribution of somatostatin receptors in normal and neoplastic human tissues: recent advances and potential relevance.Yale J Biol Med1997https://conductscience.org/library/papers/9825475PubMed
2020889358Biology, diagnosis and treatment of canine appendicular osteosarcoma: similarities and differences with human osteosarcoma.Vet J2011https://conductscience.org/library/papers/20889358PubMed

See all 43 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
39752109Canine mammary tumors as a promising adjunct preclinical model for human breast cancer research: similarities, opportunities, and challenges.Arch Pharm Res2025https://conductscience.org/library/papers/39752109PubMed
38686047Hydroxysafflor yellow A induced ferroptosis of Osteosarcoma cancer cells by HIF-1α/HK2 and SLC7A11 pathway.Oncol Res2024https://conductscience.org/library/papers/38686047PubMed
38612282The Expression Levels of CD20 as a Prognostic Value in Feline B-Cell Nasal Lymphoma: A Pilot Study.Animals (Basel)2024https://conductscience.org/library/papers/38612282PubMed
37513891Image-Based Dosimetry in Dogs and Cross-Reactivity with Human Tissues of IGF2R-Targeting Human Antibody.Pharmaceuticals (Basel)2023https://conductscience.org/library/papers/37513891PubMed

Download CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
IGF23481PubTator's text mininghttps://conductscience.org/library/genes/3481NCBI Gene
IGF2R3482PubTator's text mininghttps://conductscience.org/library/genes/3482NCBI Gene
KRT2054474PubTator's text mininghttps://conductscience.org/library/genes/54474NCBI Gene
MCAM4162PubTator's text mininghttps://conductscience.org/library/genes/4162NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36768202

GET https://conductscience.org/api/papers/v1/36768202/references?page=2